252 related articles for article (PubMed ID: 33025535)
21. The effects of erdosteine, N-acetylcysteine, and vitamin E on nicotine-induced apoptosis of pulmonary cells.
Demiralay R; Gürsan N; Erdem H
Toxicology; 2006 Feb; 219(1-3):197-207. PubMed ID: 16377052
[TBL] [Abstract][Full Text] [Related]
22. Protective role of erdosteine pretreatment on oleic acid-induced acute lung injury.
Erdem A; Gedikli E; Yersal N; Karaismailoglu S; Muftuoglu S; Fadillioglu E; Tuncer M
J Surg Res; 2017 Jun; 213():234-242. PubMed ID: 28601320
[TBL] [Abstract][Full Text] [Related]
23. Erdosteine affects eicosanoid production in COPD.
Dal Negro RW; Visconti M; Tognella S; Micheletto C
Int J Clin Pharmacol Ther; 2011 Jan; 49(1):41-5. PubMed ID: 21176724
[TBL] [Abstract][Full Text] [Related]
24. Erdosteine enhances airway response to salbutamol in patients with mild-to-moderate COPD.
Dal Negro R; Visconti M; Trevisan F; Bertacco S; Micheletto C; Tognella S
Ther Adv Respir Dis; 2008 Oct; 2(5):271-7. PubMed ID: 19124377
[TBL] [Abstract][Full Text] [Related]
25. The SH-metabolite I of erdosteine, a mucolytic drug, enhances the inhibitory effect of salbutamol on the respiratory burst of neutrophils.
Dal Sasso M; Bovio C; Culici M; Fonti E; Braga PC
Drugs Exp Clin Res; 2002; 28(4):147-54. PubMed ID: 12512232
[TBL] [Abstract][Full Text] [Related]
26. Efficacy and safety of erdosteine in the treatment of chronic rhinosinusitis with nasal polyposis - a pilot study.
Hoza J; Salzman R; Starek I; Schalek P; Kellnerova R
Rhinology; 2013 Dec; 51(4):323-7. PubMed ID: 24260764
[TBL] [Abstract][Full Text] [Related]
27. Impact of Mucolytic Agents on COPD Exacerbations: A Pair-wise and Network Meta-analysis.
Cazzola M; Rogliani P; Calzetta L; Hanania NA; Matera MG
COPD; 2017 Oct; 14(5):552-563. PubMed ID: 28753070
[TBL] [Abstract][Full Text] [Related]
28. [ Erdosteine (Mucodox), oral administration].
J Pharm Belg; 2011 Jun; (2):55-6. PubMed ID: 21823444
[No Abstract] [Full Text] [Related]
29. A controlled multicenter pediatric study in the treatment of acute respiratory tract diseases with the aid of a new specific compound, erdosteine (IPSE, Italian Pediatric Study Erdosteine).
Titti G; Lizzio A; Termini C; Negri P; Fazzio S; Mancini C
Int J Clin Pharmacol Ther; 2000 Aug; 38(8):402-7. PubMed ID: 10984014
[TBL] [Abstract][Full Text] [Related]
30. Erdosteine treatment attenuates oxidative stress and fibrosis in experimental biliary obstruction.
Sener G; Sehirli AO; Toklu HZ; Yuksel M; Ercan F; Gedik N
Pediatr Surg Int; 2007 Mar; 23(3):233-41. PubMed ID: 17216233
[TBL] [Abstract][Full Text] [Related]
31. Antioxidant effect of erdosteine and lipoic acid in ovarian ischemia-reperfusion injury.
Dokuyucu R; Karateke A; Gokce H; Kurt RK; Ozcan O; Ozturk S; Tas ZA; Karateke F; Duru M
Eur J Obstet Gynecol Reprod Biol; 2014 Dec; 183():23-7. PubMed ID: 25461347
[TBL] [Abstract][Full Text] [Related]
32. Protective effect of erdosteine against hypochlorous acid-induced acute lung injury and lipopolysaccharide-induced neutrophilic lung inflammation in mice.
Hayashi K; Hosoe H; Kaise T; Ohmori K
J Pharm Pharmacol; 2000 Nov; 52(11):1411-6. PubMed ID: 11186250
[TBL] [Abstract][Full Text] [Related]
33. Protective effect of erdosteine metabolite I against hydrogen peroxide-induced oxidative DNA-damage in lung epithelial cells.
Marabini L; Calò R; Braga PC
Arzneimittelforschung; 2011; 61(12):700-6. PubMed ID: 22282957
[TBL] [Abstract][Full Text] [Related]
34. The protective effect of erdosteine against cyclosporine A-induced cardiotoxicity in rats.
Selcoki Y; Uz E; Bayrak R; Sahin S; Kaya A; Uz B; Karanfil A; Ozkara A; Akcay A
Toxicology; 2007 Sep; 239(1-2):53-9. PubMed ID: 17689165
[TBL] [Abstract][Full Text] [Related]
35. Clinical effects of erdosteine in the treatment of acute respiratory tract diseases in children.
Balli F; Bergamini B; Calistru P; Ciofu EP; Domenici R; Doros G; Dragomir D; Gherghina I; Iordachescu F; Murgoci G; Orasanu D; Plesca D; Vaccaro A; Assereto R
Int J Clin Pharmacol Ther; 2007 Jan; 45(1):16-22. PubMed ID: 17256446
[TBL] [Abstract][Full Text] [Related]
36. Tissue-Protective Effect of Erdosteine on Multiple-Organ Injuries Induced by Fine Particulate Matter.
Cao L; Ping F; Zhang F; Gao H; Li P; Ning X; Cui G; Ma Z; Jiang X; Li S; Han S
Med Sci Monit; 2021 Dec; 27():e930909. PubMed ID: 34873140
[TBL] [Abstract][Full Text] [Related]
37. Effect of the mucolytic erdosteine on the success rate of PPI-based first-line triple therapy for Helicobacter pylori eradication: a prospective, double-blind, randomized, placebo-controlled study.
Abut E; Yaşar B; Güveli H; Bölükbaş C; Bölükbaş FF; Dalay AR; Kurdaş OO
Scand J Gastroenterol; 2010 Jun; 45(6):677-83. PubMed ID: 20334478
[TBL] [Abstract][Full Text] [Related]
38. The effect of erdosteine on airway defence mechanisms and inflammatory cytokines in the settings of allergic inflammation.
Fraňová S; Kazimierová I; Pappová L; Molitorisová M; Jošková M; Šutovská M
Pulm Pharmacol Ther; 2019 Feb; 54():60-67. PubMed ID: 30502381
[TBL] [Abstract][Full Text] [Related]
39. Protective role of erdosteine on vancomycin-induced oxidative stress in rat liver.
Sahin M; Cam H; Olgar S; Tunc SE; Arslan C; Uz E; Yilmaz HR
Mol Cell Biochem; 2006 Oct; 291(1-2):155-60. PubMed ID: 16733804
[TBL] [Abstract][Full Text] [Related]
40. Erdosteine reduces inflammation and time to first exacerbation postdischarge in hospitalized patients with AECOPD.
Moretti M; Fagnani S
Int J Chron Obstruct Pulmon Dis; 2015; 10():2319-25. PubMed ID: 26604731
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
